<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00567346</url>
  </required_header>
  <id_info>
    <org_study_id>AB0602</org_study_id>
    <secondary_id>2006-001548-30</secondary_id>
    <nct_id>NCT00567346</nct_id>
  </id_info>
  <brief_title>Efficacy and Safety of Grass Pollen Sublingual Immunotherapy</brief_title>
  <official_title>A Randomised, DB, Plcb Controlled, Multicentre, Multinational Phase II/III Study to Assess the Efficacy and Safety of Three Different Dose Regimens of Oralgen Grass Pollen in Patients With Grass Pollen Related Allergic Rhinoconjunctivitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Artu Biologicals</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Artu Biologicals</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study is assessing efficacy and safety of three different dosage regimens of grass pollen
      sublingual immunotherapy in adult patients suffering from grass pollen related
      rhinoconjunctivitis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients with seasonal grass pollen related rhinoconjunctivitis will be randomized to one of
      four treatment groups at 41 centres in Europe. Each treatment group will consist of
      approximately 150 patients and 150 patients will be randomized to a placebo group. The study
      will consist of a screening phase, a treatment phase and a variable maintenance period.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2006</start_date>
  <completion_date type="Actual">March 2008</completion_date>
  <primary_completion_date type="Actual">October 2007</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Primary efficacy variable is based on pollen season rhinoconjunctivitis Total Symptom Score (PS.RTSS)</measure>
    <time_frame>One year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Diarised Period RTSS on severity of rhinoconjunctivitis scores and rescue medication usage will be calculated to assess efficacy. Safety will be assessed through AE profile, the assessment of routine safety tests.</measure>
    <time_frame>one year</time_frame>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">605</enrollment>
  <condition>Allergic Rhinoconjunctivitis</condition>
  <arm_group>
    <arm_group_label>grass pollen extract twice weekly</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Current standard dose regimen of grass pollen immunotherapy (9,500 BU), given twice weekly. Note: patients in twice weekly dosing regimen will also receive placebo on days no active treatment is given.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Grass pollen extract, daily</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Grass pollen immunotherapy, 9,500 BU, given daily</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Increased dose of grass pollen extract</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Increased dose of grass pollen immunotherapy, 19,000 BU, given daily</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Patients randomized to placebo will receive placebo daily.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Oralgen</intervention_name>
    <description>Patients will receive drops of grass pollen immunotherapy sublingually</description>
    <arm_group_label>grass pollen extract twice weekly</arm_group_label>
    <arm_group_label>Grass pollen extract, daily</arm_group_label>
    <arm_group_label>Increased dose of grass pollen extract</arm_group_label>
    <other_name>grass pollen extract</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>grass pollen extract</intervention_name>
    <description>Patients will receive matching placebo sublingually</description>
    <arm_group_label>Placebo control</arm_group_label>
    <other_name>Placebo control</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  male or female aged 18-50

          -  patients with grass pollen related allergic rhinoconjunctivitis for at least 2 pollen
             seasons

          -  Positive skin prick test and IgE value of at least Class 2+

          -  RTSS of greater or equal to 14 during pollen season prior tot the start of the study

          -  Patients must be in general good health

          -  Patients with normal spirometry

          -  Informed consent given and willing to comply with the protocol

          -  Female patients are eligible if they use an accepted contraceptive method

          -  Negative urine pregnancy test if female

        Exclusion Criteria:

          -  Pregnancy, breast feeding

          -  Asthma requiring treatment other than beta-2 inhaled agonists

          -  patients who have taken oral steroids within 12 weeks before screening visit

          -  patients who have received desensitisation treatment for grass pollen

          -  treatment by immunotherapy with any other allergen within the previous 5 years

          -  patients who have suffered a lower respiratory tract infection within 4 weeks or an
             upper respiratory tract infection within 2 weeks of the screening visit

          -  patients at risk of non-compliance

          -  participation in any other clinical study within the previous 3 months

          -  patients with a past or current disease, which may affect participation in or outcome
             of this study.

          -  patients treated with beta-blockers or under continuous corticotherapy

          -  allergic sensitivity to epithelial allergens the patients is exposed to

          -  positive skin prick test for environmental allergens and suffering from serious
             allergic symptoms due to exposure to these allergens during study period

          -  intention to subject the patient to surgery of the nasal cavity during current study

          -  Usual contraindications of immunotherapy

          -  a clinical history of symptomatic seasonal allergic rhinitis and/or asthma due to tree
             pollen or weed pollen adjacent to the start of, and potentially overlapping the grass
             pollen season
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Folkert R Roossien</last_name>
    <role>Study Director</role>
    <affiliation>Artu-Biologicals Europe B.V., the Netherlands</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>MHAT PLovdiv, ENT Clinic</name>
      <address>
        <city>Plovdiv</city>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>5th MHAT, ENT Clinic</name>
      <address>
        <city>Sofia</city>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Military Medical Academy</name>
      <address>
        <city>Sofia</city>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ministry of interior-central clinical database</name>
      <address>
        <city>Sofia</city>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>MHAT Sveta Marina</name>
      <address>
        <city>Varna</city>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Military Medical Academy</name>
      <address>
        <city>Varna</city>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fakultni nemocnice Brno</name>
      <address>
        <city>Brno-Bohunice</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ORL Soukroma praxe</name>
      <address>
        <city>Brno</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nemocnice Caslav</name>
      <address>
        <city>Caslav</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Alergologicka ordinace</name>
      <address>
        <city>Dobruska</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Alergologicka ambulance</name>
      <address>
        <city>Jablonec nad Nisou</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Alergologicka ordinace</name>
      <address>
        <city>Kutna Hora</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Alergologicka ambulance</name>
      <address>
        <city>Ostrava - Hrabuvka</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ambulance plicni a alergologicka</name>
      <address>
        <city>Ostrave - Hrabuvka</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Alergologicka ambulance Okresni nemocnice Tabor</name>
      <address>
        <city>Tabor</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Berufsgen. kliniken Bergmannsheil</name>
      <address>
        <city>Bochum</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Univ. klinikum Carl Gustav Carus</name>
      <address>
        <city>Dresden</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>MedicoKIT</name>
      <address>
        <city>Goch</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Johannes-Gutenberg-Universitat Mainz</name>
      <address>
        <city>Mainz</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vital Care</name>
      <address>
        <city>Muenchen</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Privataertz. inst. &amp; Forsh. einrichtung</name>
      <address>
        <city>Wiesbaden</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Svabhegyi Allami Gyermekgyogyintezet pulmonologia</name>
      <address>
        <city>Budapest</city>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Szent Janos Korhaz</name>
      <address>
        <city>Budapest</city>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Selye Janos Korhaz</name>
      <address>
        <city>Komarom</city>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Karolina Korhaz</name>
      <address>
        <city>Mosomagyarovar</city>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tudogyogyintezet Torokbalint</name>
      <address>
        <city>Torokbalint</city>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kaunas medical University hospital</name>
      <address>
        <city>Kaunas</city>
        <country>Lithuania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klaipeda Regional Hospital</name>
      <address>
        <city>Klaipeda</city>
        <country>Lithuania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>JSC Seimos gydytojas</name>
      <address>
        <city>Vilnius</city>
        <country>Lithuania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vilnius Central Outpatient Clinic</name>
      <address>
        <city>Vilnius</city>
        <country>Lithuania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vilnius university hospital, Santariskiu Clinic</name>
      <address>
        <city>Vilnius</city>
        <country>Lithuania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ampha</name>
      <address>
        <city>De Bilt</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ampha</name>
      <address>
        <city>Den Bosch</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ampha</name>
      <address>
        <city>Hengelo</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Menox</name>
      <address>
        <city>Nijmegen</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centrum imunologie a alergologie s.r.o</name>
      <address>
        <city>Bratislava</city>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>FNsP Nove Zamky, ambulancia TaRCh</name>
      <address>
        <city>Nove Zamky</city>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Amb. klinickey imunologie a allergologie UTaRCH</name>
      <address>
        <city>Poprad</city>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ambulancia klinickej imunologie a alergologie</name>
      <address>
        <city>Trencin</city>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medcentrum s.r.o.</name>
      <address>
        <city>Zilina</city>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Bulgaria</country>
    <country>Czech Republic</country>
    <country>Germany</country>
    <country>Hungary</country>
    <country>Lithuania</country>
    <country>Netherlands</country>
    <country>Slovakia</country>
  </location_countries>
  <verification_date>May 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 3, 2007</study_first_submitted>
  <study_first_submitted_qc>December 3, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 4, 2007</study_first_posted>
  <last_update_submitted>May 4, 2010</last_update_submitted>
  <last_update_submitted_qc>May 4, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 5, 2010</last_update_posted>
  <responsible_party>
    <name_title>Dr. F.F. Roosien</name_title>
    <organization>Artu Biologicals</organization>
  </responsible_party>
  <keyword>randomised</keyword>
  <keyword>double-blind</keyword>
  <keyword>placebo-controlled</keyword>
  <keyword>efficacy and safety</keyword>
  <keyword>Oralgen® Grass Pollen</keyword>
  <keyword>allergic rhinoconjunctivitis</keyword>
  <keyword>Allergy</keyword>
  <keyword>Rhinoconjunctivitis</keyword>
  <keyword>Immunotherapy</keyword>
  <keyword>Grass pollen extract</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Conjunctivitis</mesh_term>
    <mesh_term>Conjunctivitis, Allergic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

